Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMS II Study
NCT00243906Phase 2Completed
- Sponsor
- University of Cincinnati
- Start
- Jan 2003
- Primary completion
- May 2006
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in ischemic stroke, sponsored by University of Cincinnati. Started Jan 2003; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00243906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243906.